CNS Redox Homeostasis and Dysfunction in Neurodegenerative Diseases
Abstract
:1. Introduction
2. Redox Homeostasis in Mitochondria and Production of ROS
2.1. Alzheimer’s Disease
2.2. Parkinson’s Disease
2.3. Amyotrophic Lateral Sclerosis
2.4. Huntington’s Disease
3. Link between ER Stress and Neuroinflammation
3.1. Alzheimer’s Disease
3.2. Parkinson’s Disease
3.3. Amyotrophic Lateral Sclerosis
3.4. Huntington’s Disease
4. Redox Imbalance and Protein Misfolding in Neurodegeneration
4.1. Alzheimer’s Disease
4.2. Parkinson’s Disease
4.3. Amyotrophic Lateral Sclerosis
4.4. Huntington’s Disease
5. Ferroptosis
5.1. Alzheimer’s Disease
5.2. Parkinson’s Disease
5.3. Amyotrophic Lateral Sclerosis
5.4. Huntington’s Disease
6. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Koch, R.E.; Buchanan, K.L.; Casagrande, S.; Crino, O.; Dowling, D.K.; Hill, G.E.; Hood, W.R.; McKenzie, M.; Mariette, M.M.; Noble, D.W.; et al. Integrating Mitochondrial Aerobic Metabolism into Ecology and Evolution. Trends Ecol. Evol. 2021, 36, 321–332. [Google Scholar] [CrossRef] [PubMed]
- Goldsteins, G.; Keksa-Goldsteine, V.; Ahtoniemi, T.; Jaronen, M.; Arens, E.; Åkerman, K.; Chan, P.H.; Koistinaho, J. Deleterious Role of Superoxide Dismutase in the Mitochondrial Intermembrane Space. J. Biol. Chem. 2008, 283, 8446–8452. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pereverzev, M.O.; Vygodina, T.V.; Konstantinov, A.A.; Skulachev, V.P. Cytochrome c, an ideal antioxidant. Biochem. Soc. Trans. 2003, 31, 1312–1315. [Google Scholar] [CrossRef] [PubMed]
- Kagan, V.E.; Bayır, H.A.; Belikova, N.A.; Kapralov, O.; Tyurina, Y.Y.; Tyurin, V.A.; Jiang, J.; Stoyanovsky, D.A.; Wipf, P.; Kochanek, P.M.; et al. Cytochrome c/cardiolipin relations in mitochondria: A kiss of death. Free Radic. Biol. Med. 2009, 46, 1439–1453. [Google Scholar] [CrossRef] [Green Version]
- Finkel, T. Signal transduction by reactive oxygen species. J. Cell Biol. 2011, 194, 7–15. [Google Scholar] [CrossRef] [Green Version]
- Jia, Q.; Sieburth, D. Mitochondrial hydrogen peroxide positively regulates neuropeptide secretion during diet-induced activation of the oxidative stress response. Nat. Commun. 2021, 12, 2304. [Google Scholar] [CrossRef]
- Jeong, E.-S.; Bajgai, J.; You, I.-S.; Rahman, H.; Fadriquela, A.; Sharma, S.; Kwon, H.-U.; Lee, S.-Y.; Kim, C.-S.; Lee, K.-J. Therapeutic Effects of Hydrogen Gas Inhalation on Trimethyltin-Induced Neurotoxicity and Cognitive Impairment in the C57BL/6 Mice Model. Int. J. Mol. Sci. 2021, 22, 13313. [Google Scholar] [CrossRef]
- Gandhi, S.; Abramov, A.Y. Mechanism of oxidative stress in neurodegeneration. Oxid. Med. Cell. Longev. 2012, 2012, 428010. [Google Scholar] [CrossRef] [Green Version]
- Casley, C.S.; Canevari, L.; Land, J.M.; Clark, J.B.; Sharpe, M.A. β-Amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J. Neurochem. 2002, 80, 91–100. [Google Scholar] [CrossRef]
- Sukhorukov, V.; Voronkov, D.; Baranich, T.; Mudzhiri, N.; Magnaeva, A.; Illarioshkin, S. Impaired Mitophagy in Neurons and Glial Cells during Aging and Age-Related Disorders. Int. J. Mol. Sci. 2021, 22, 10251. [Google Scholar] [CrossRef]
- Blennow, K.; de Leon, M.; Zetterberg, H. Alzheimer’s disease. Lancet 2006, 368, 387–403. [Google Scholar] [CrossRef]
- Waring, S.C.; Rosenberg, R.N. Genome-Wide Association Studies in Alzheimer Disease. Arch. Neurol. 2008, 65, 329–334. [Google Scholar] [CrossRef] [Green Version]
- Swerdlow, R.H. Mitochondria and Mitochondrial Cascades in Alzheimer’s Disease. J. Alzheimer’s Dis. 2018, 62, 1403–1416. [Google Scholar] [CrossRef] [Green Version]
- Wang, X.; Wang, W.; Li, L.; Perry, G.; Lee, H.-G.; Zhu, X. Oxidative stress and mitochondrial dysfunction in Alzheimer’s disease. Biochim. Biophys. Acta 2014, 1842, 1240–1247. [Google Scholar] [CrossRef] [Green Version]
- Gordon, B.A.; Blazey, T.M.; Su, Y.; Hari-Raj, A.; Dincer, A.; Flores, S.; Christensen, J.; McDade, E.; Wang, G.; Xiong, C.; et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer’s disease: A longitudinal study. Lancet Neurol. 2018, 17, 241–250. [Google Scholar] [CrossRef] [Green Version]
- Croteau, E.; Castellano, C.-A.; Fortier, M.; Bocti, C.; Fulop, T.; Paquet, N.; Cunnane, S. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer’s disease. Exp. Gerontol. 2018, 107, 18–26. [Google Scholar] [CrossRef]
- Wang, W.; Zhao, F.; Ma, X.; Perry, G.; Zhu, X. Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: Recent advances. Mol. Neurodegener. 2020, 15, 30. [Google Scholar] [CrossRef]
- Hirai, K.; Aliev, G.; Nunomura, A.; Fujioka, H.; Russell, R.L.; Atwood, C.S.; Johnson, A.B.; Kress, Y.; Vinters, H.V.; Tabaton, M.; et al. Mitochondrial Abnormalities in Alzheimer’s Disease. J. Neurosci. 2001, 21, 3017–3023. [Google Scholar] [CrossRef] [Green Version]
- Martín-Maestro, P.; Gargini, R.; Perry, G.; Avila, J.; García-Escudero, V. PARK2 enhancement is able to compensate mitophagy alterations found in sporadic Alzheimer’s disease. Hum. Mol. Genet. 2015, 25, 792–806. [Google Scholar] [CrossRef] [Green Version]
- Qin, W.; Haroutunian, V.; Katsel, P.; Cardozo, C.P.; Ho, L.; Buxbaum, J.; Pasinetti, G.M. PGC-1α Expression Decreases in the Alzheimer Disease Brain as a Function of Dementia. Arch. Neurol. 2009, 66, 352–361. [Google Scholar] [CrossRef]
- Area-Gomez, E.; De Groof, A.; Bonilla, E.; Montesinos, J.; Tanji, K.; Boldogh, I.; Pon, L.; Schon, E.A. A key role for MAM in mediating mitochondrial dysfunction in Alzheimer disease. Cell Death Dis. 2018, 9, 335. [Google Scholar] [CrossRef] [Green Version]
- Wang, X.; Su, B.; Siedlak, S.L.; Moreira, P.I.; Fujioka, H.; Wang, Y.; Casadesus, G.; Zhu, X. Amyloid- overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc. Natl. Acad. Sci. USA 2008, 105, 19318–19323. [Google Scholar] [CrossRef] [Green Version]
- Wang, W.; Yin, J.; Ma, X.; Zhao, F.; Siedlak, S.L.; Wang, Z.; Torres, S.; Fujioka, H.; Xu, Y.; Perry, G.; et al. Inhibition of mitochondrial fragmentation protects against Alzheimer’s disease in rodent model. Hum. Mol. Genet. 2017, 26, 4118–4131. [Google Scholar] [CrossRef] [Green Version]
- Wang, X.; Su, B.; Lee, H.-G.; Li, X.; Perry, G.; Smith, M.A.; Zhu, X. Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer’s Disease. J. Neurosci. 2009, 29, 9090–9103. [Google Scholar] [CrossRef]
- Choi, H.; Kim, H.J.; Kim, J.; Kim, S.; Yang, J.; Lee, W.; Park, Y.; Hyeon, S.J.; Lee, D.-S.; Ryu, H.; et al. Increased acetylation of Peroxiredoxin1 by HDAC6 inhibition leads to recovery of Aβ-induced impaired axonal transport. Mol. Neurodegener. 2017, 12, 23. [Google Scholar] [CrossRef] [Green Version]
- Dickson, D.W. Parkinson’s Disease and Parkinsonism: Neuropathology. Cold Spring Harb. Perspect. Med. 2012, 2, a009258. [Google Scholar] [CrossRef] [Green Version]
- Klein, C.; Westenberger, A. Genetics of Parkinson’s Disease. Cold Spring Harb. Perspect. Med. 2012, 2, a008888. [Google Scholar] [CrossRef] [Green Version]
- Hsu, L.J.; Sagara, Y.; Arroyo, A.; Rockenstein, E.; Sisk, A.; Mallory, M.; Wong, J.; Takenouchi, T.; Hashimoto, M.; Masliah, E. α-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress. Am. J. Pathol. 2000, 157, 401–410. [Google Scholar] [CrossRef]
- Martínez, J.H.; Fuentes, F.; Vanasco, V.; Alvarez, S.; Alaimo, A.; Cassina, A.; Leskow, F.C.; Velazquez, F. Alpha-synuclein mitochondrial interaction leads to irreversible translocation and complex I impairment. Arch. Biochem. Biophys. 2018, 651, 1–12. [Google Scholar] [CrossRef] [Green Version]
- Prots, I.; Grosch, J.; Brazdis, R.-M.; Simmnacher, K.; Veber, V.; Havlicek, S.; Hannappel, C.; Krach, F.; Krumbiegel, M.; Schütz, O.; et al. α-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies. Proc. Natl. Acad. Sci. USA 2018, 115, 7813–7818. [Google Scholar] [CrossRef] [Green Version]
- Shaltouki, A.; Hsieh, C.-H.; Kim, M.J.; Wang, X. Alpha-synuclein delays mitophagy and targeting Miro rescues neuron loss in Parkinson’s models. Acta Neuropathol. 2018, 136, 607–620. [Google Scholar] [CrossRef]
- Park, J.-H.; Burgess, J.D.; Faroqi, A.H.; DeMeo, N.N.; Fiesel, F.C.; Springer, W.; Delenclos, M.; McLean, P.J. Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway. Mol. Neurodegener. 2020, 15, 5. [Google Scholar] [CrossRef] [Green Version]
- Sonninen, T.-M.; Goldsteins, G.; Laham-Karam, N.; Koistinaho, J.; Lehtonen, L. Proteostasis Disturbances and Inflammation in Neurodegenerative Diseases. Cells 2020, 9, 2183. [Google Scholar] [CrossRef]
- DeJesus-Hernandez, M.; Mackenzie, I.R.; Boeve, B.F.; Boxer, A.L.; Baker, M.; Rutherford, N.J.; Nicholson, A.M.; Finch, N.A.; Flynn, H.; Adamson, J.; et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron 2011, 72, 245–256. [Google Scholar] [CrossRef] [Green Version]
- Leko, M.B.; Župunski, V.; Kirincich, J.; Smilović, D.; Hortobágyi, T.; Hof, P.R.; Šimić, G. Molecular Mechanisms of Neurodegeneration Related to C9orf72 Hexanucleotide Repeat Expansion. Behav. Neurol. 2019, 2019, 2909168. [Google Scholar] [CrossRef] [Green Version]
- Trageser, K.; Smith, C.; Herman, F.J.; Ono, K.; Pasinetti, G.M. Mechanisms of Immune Activation by c9orf72-Expansions in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Front. Neurosci. 2019, 13, 1298. [Google Scholar] [CrossRef]
- Wang, T.; Liu, H.; Itoh, K.; Oh, S.; Zhao, L.; Murata, D.; Sesaki, H.; Hartung, T.; Na, C.H.; Wang, J. C9orf72 regulates energy homeostasis by stabilizing mitochondrial complex I assembly. Cell Metab. 2021, 33, 531–546.e9. [Google Scholar] [CrossRef]
- Mehta, A.R.; Gregory, J.M.; Dando, O.; Carter, R.N.; Burr, K.; Nanda, J.; Story, D.; McDade, K.; Smith, C.; Morton, N.M.; et al. Mitochondrial bioenergetic deficits in C9orf72 amyotrophic lateral sclerosis motor neurons cause dysfunctional axonal homeostasis. Acta Neuropathol. 2021, 141, 257–279. [Google Scholar] [CrossRef]
- Ahtoniemi, T.; Jaronen, M.; Keksa-Goldsteine, V.; Goldsteins, G.; Koistinaho, J. Mutant SOD1 from spinal cord of G93A rats is destabilized and binds to inner mitochondrial membrane. Neurobiol. Dis. 2008, 32, 479–485. [Google Scholar] [CrossRef]
- Jiang, Z.; Wang, W.; Perry, G.; Zhu, X.; Wang, X. Mitochondrial dynamic abnormalities in amyotrophic lateral sclerosis. Transl. Neurodegener. 2015, 4, 14. [Google Scholar] [CrossRef] [Green Version]
- Sun, X.; Song, J.; Huang, H.; Chen, H.; Qian, K. Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells. Stem Cell Res. Ther. 2018, 9, 315. [Google Scholar] [CrossRef] [Green Version]
- Delic, V.; Kurien, C.; Cruz, J.; Zivkovic, S.; Barretta, J.; Thomson, A.; Hennessey, D.; Joseph, J.; Ehrhart, J.; Willing, A.E.; et al. Discrete mitochondrial aberrations in the spinal cord of sporadic ALS patients. J. Neurosci. Res. 2018, 96, 1353–1366. [Google Scholar] [CrossRef]
- Alves, C.J.; Dariolli, R.; Jorge, F.M.D.H.; Monteiro, M.R.; Maximino, J.R.; Martins, R.S.; Strauss, B.E.; Krieger, J.E.; Callegaro, D.; Chadi, G.; et al. Gene expression profiling for human iPS-derived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial functions and neurodegeneration. Front. Cell. Neurosci. 2015, 9. [Google Scholar] [CrossRef] [Green Version]
- Rahman, M.H.; Bajgai, J.; Fadriquela, A.; Sharma, S.; Trinh Thi, T.; Akter, R.; Goh, S.H.; Kim, C.-S.; Lee, K.-J. Redox Effects of Molecular Hydrogen and Its Therapeutic Efficacy in the Treatment of Neurodegenerative Diseases. Processes 2021, 9, 308. [Google Scholar] [CrossRef]
- Singh, T.; Jiao, Y.; Ferrando, L.M.; Yablonska, S.; Li, F.; Horoszko, E.C.; Lacomis, D.; Friedlander, R.M.; Carlisle, D.L. Neuronal mitochondrial dysfunction in sporadic amyotrophic lateral sclerosis is developmentally regulated. Sci. Rep. 2021, 11, 18916. [Google Scholar] [CrossRef]
- Parsons, M.P.; Raymond, L.A. Huntington Disease. In Neurobiology of Brain Disorders: Biological Basis of Neurological and Psychiatric Disorders; Academic Press: Cambridge, MA, USA, 2015; pp. 303–320. [Google Scholar] [CrossRef]
- Myers, R.H. Huntington’s disease genetics. NeuroRX 2004, 1, 255–262. [Google Scholar] [CrossRef]
- Paul, B.D.; Snyder, S.H. Impaired Redox Signaling in Huntington’s Disease: Therapeutic Implications. Front. Mol. Neurosci. 2019, 12, 68. [Google Scholar] [CrossRef] [Green Version]
- Cui, L.; Jeong, H.; Borovecki, F.; Parkhurst, C.N.; Tanese, N.; Krainc, D. Transcriptional Repression of PGC-1α by Mutant Huntingtin Leads to Mitochondrial Dysfunction and Neurodegeneration. Cell 2006, 127, 59–69. [Google Scholar] [CrossRef] [Green Version]
- Jenkins, B.G.; Koroshetz, W.J.; Beal, M.F.; Rosen, B.R. Evidence for irnnairment of energy metabofism in vivo in Huntington’s disease using localized 1H NMR spectroscopy. Neurology 1993, 43, 2689. [Google Scholar] [CrossRef]
- Browne, S.E.; Bowling, A.C.; MacGarvey, U.; Baik, M.J.; Berger, S.C.; Muqit, M.M.; Bird, E.D.; Beal, M.F. Oxidative damage and metabolic dysfunction in Huntington’s disease: Selective vulnerability of the basal ganglia. Ann. Neurol. 1997, 41, 646–653. [Google Scholar] [CrossRef]
- Soto, C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat. Rev. Neurosci. 2003, 4, 49–60. [Google Scholar] [CrossRef] [PubMed]
- Schröder, M.; Kaufman, R.J. The mammalian unfolded protein response. Annu. Rev. Biochem. 2005, 74, 739–789. [Google Scholar] [CrossRef] [PubMed]
- Ghemrawi, R.; Khair, M. Endoplasmic Reticulum Stress and Unfolded Protein Response in Neurodegenerative Diseases. Int. J. Mol. Sci. 2020, 21, 6127. [Google Scholar] [CrossRef]
- Zhang, K.; Kaufman, R.J. From endoplasmic-reticulum stress to the inflammatory response. Nature 2008, 454, 455–462. [Google Scholar] [CrossRef] [Green Version]
- Tam, A.B.; Mercado, E.L.; Hoffmann, A.; Niwa, M. ER Stress Activates NF-κB by Integrating Functions of Basal IKK Activity, IRE1 and PERK. PLoS ONE 2012, 7, e45078. [Google Scholar] [CrossRef] [Green Version]
- Hu, P.; Han, Z.; Couvillon, A.D.; Kaufman, R.J.; Exton, J.H. Autocrine Tumor Necrosis Factor Alpha Links Endoplasmic Reticulum Stress to the Membrane Death Receptor Pathway through IRE1α-Mediated NF-κB Activation and Down-Regulation of TRAF2 Expression. Mol. Cell. Biol. 2006, 26, 3071–3084. [Google Scholar] [CrossRef] [Green Version]
- Grootjans, J.; Kaser, A.; Kaufman, R.J.; Blumberg, R.S. The unfolded protein response in immunity and inflammation. Nat. Rev. Immunol. 2016, 16, 469–484. [Google Scholar] [CrossRef] [Green Version]
- Sprenkle, N.T.; Sims, S.; Sánchez, C.L.; Meares, G.P. Endoplasmic reticulum stress and inflammation in the central nervous system. Mol. Neurodegener. 2017, 12, 42. [Google Scholar] [CrossRef]
- Cabral-Miranda, F.; Hetz, C. ER stress in neurodegenerative disease: From disease mechanisms to therapeutic interventions. Endoplasmic Reticulum Stress Dis. 2017, 4, 11–26. [Google Scholar] [CrossRef]
- Yang, Z.; Shao, Y.; Zhao, Y.; Li, Q.; Li, R.; Xiao, H.; Zhang, F.; Zhang, Y.; Chang, X.; Zhang, Y.; et al. Endoplasmic reticulum stress-related neuroinflammation and neural stem cells decrease in mice exposure to paraquat. Sci. Rep. 2020, 10, 17757. [Google Scholar] [CrossRef]
- Fernández, D.; Geisse, A.; Bernales, J.I.; Lira, A.; Osorio, F. The Unfolded Protein Response in Immune Cells as an Emerging Regulator of Neuroinflammation. Front. Aging Neurosci. 2021, 13, 286. [Google Scholar] [CrossRef]
- Uddin, M.S.; Tewari, D.; Sharma, G.; Kabir, M.T.; Barreto, G.E.; Bin-Jumah, M.N.; Perveen, A.; Abdel-Daim, M.M.; Ashraf, G.M. Molecular Mechanisms of ER Stress and UPR in the Pathogenesis of Alzheimer’s Disease. Mol. Neurobiol. 2020, 57, 2902–2919. [Google Scholar] [CrossRef]
- Buchanan, H.; Mackay, M.; Palmer, K.; Tothová, K.; Katsur, M.; Platt, B.; Koss, D.J. Synaptic Loss, ER Stress and Neuro-Inflammation Emerge Late in the Lateral Temporal Cortex and Associate with Progressive Tau Pathology in Alzheimer’s Disease. Mol. Neurobiol. 2020, 57, 3258–3272. [Google Scholar] [CrossRef]
- Kondo, T.; Asai, M.; Tsukita, K.; Kutoku, Y.; Ohsawa, Y.; Sunada, Y.; Imamura, K.; Egawa, N.; Yahata, N.; Okita, K.; et al. Modeling Alzheimer’s Disease with iPSCs Reveals Stress Phenotypes Associated with Intracellular Aβ and Differential Drug Responsiveness. Cell Stem Cell 2013, 12, 487–496. [Google Scholar] [CrossRef] [Green Version]
- Oksanen, M.; Petersen, A.J.; Naumenko, N.; Puttonen, K.; Lehtonen, S.; Olivé, M.G.; Shakirzyanova, A.; Leskelä, S.; Sarajärvi, T.; Viitanen, M.; et al. PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer’s Disease. Stem Cell Rep. 2017, 9, 1885–1897. [Google Scholar] [CrossRef] [Green Version]
- Salminen, A.; Kaarniranta, K.; Kauppinen, A. ER stress activates immunosuppressive network: Implications for aging and Alzheimer’s disease. Klin. Wochenschr. 2020, 98, 633–650. [Google Scholar] [CrossRef] [Green Version]
- Hampel, H.; Caraci, F.; Cuello, A.C.; Caruso, G.; Nisticò, R.; Corbo, M.; Baldacci, F.; Toschi, N.; Garaci, F.; Chiesa, P.A.; et al. A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer’s Disease. Front. Immunol. 2020, 11, 456. [Google Scholar] [CrossRef]
- Kinney, J.W.; BeMiller, S.M.; Murtishaw, A.S.; Leisgang, A.M.; Salazar, A.M.; Lamb, B.T. Inflammation as a central mechanism in Alzheimer’s disease. Alzheimer’s Dement. Transl. Res. Clin. Interv. 2018, 4, 575–590. [Google Scholar] [CrossRef]
- Heneka, M.T.; O’Banion, M.K. Inflammatory processes in Alzheimer’s disease. J. Neuroimmunol. 2007, 184, 69–91. [Google Scholar] [CrossRef]
- Da Costa, C.A.; El Manaa, W.; Duplan, E.; Checler, F. The Endoplasmic Reticulum Stress/Unfolded Protein Response and Their Contributions to Parkinson’s Disease Physiopathology. Cells 2020, 9, 2495. [Google Scholar] [CrossRef]
- Lehtonen, S.; Jaronen, M.; Vehviläinen, P.; Lakso, M.; Rudgalvyte, M.; Keksa-Goldsteine, V.; Wong, G.; Courtney, M.J.; Koistinaho, J.; Goldsteins, G. Inhibition of Excessive Oxidative Protein Folding Is Protective in MPP+ Toxicity-Induced Parkinson’s Disease Models. Antioxid. Redox Signal. 2016, 25, 485–497. [Google Scholar] [CrossRef] [PubMed]
- Hoffstrom, B.G.; Kaplan, A.; Letso, R.; Schmid, R.S.; Turmel, G.J.; Lo, D.C.; Stockwell, B.R. Inhibitors of protein disulfide isomerase suppress apoptosis induced by misfolded proteins. Nat. Chem. Biol. 2010, 6, 900–906. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jaronen, M.; Vehviläinen, P.; Malm, T.; Keksa-Goldsteine, V.; Pollari, E.; Valonen, P.; Koistinaho, J.; Goldsteins, G. Protein disulfide isomerase in ALS mouse glia links protein misfolding with NADPH oxidase-catalyzed superoxide production. Hum. Mol. Genet. 2012, 22, 646–655. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hetz, C.; Thielen, P.; Matus, S.; Nassif, M.; Court, F.; Kiffin, R.; Martinez, G.; Cuervo, A.M.; Brown, R.H.; Glimcher, L.H. XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes Dev. 2009, 23, 2294–2306. [Google Scholar] [CrossRef] [Green Version]
- Duennwald, M.L.; Lindquist, S. Impaired ERAD and ER stress are early and specific events in polyglutamine toxicity. Genes Dev. 2008, 22, 3308–3319. [Google Scholar] [CrossRef] [Green Version]
- Matus, S.; Lisbona, F.; Torres, M.; Leon, C.; Thielen, P.; Hetz, C. The Stress Rheostat: An Interplay Between the Unfolded Protein Response (UPR) and Autophagy in Neurodegeneration. Curr. Mol. Med. 2008, 8, 157–172. [Google Scholar] [CrossRef]
- Singhrao, S.; Neal, J.; Morgan, P.; Gasque, P. Increased Complement Biosynthesis by Microglia and Complement Activation on Neurons in Huntington’s Disease. Exp. Neurol. 1999, 159, 362–376. [Google Scholar] [CrossRef]
- Möller, T. Neuroinflammation in Huntington’s disease. J. Neural Transm. 2010, 117, 1001–1008. [Google Scholar] [CrossRef]
- Braakman, I.; Bulleid, N.J. Protein Folding and Modification in the Mammalian Endoplasmic Reticulum. Annu. Rev. Biochem. 2011, 80, 71–99. [Google Scholar] [CrossRef]
- Walter, P.; Ron, D. The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation. Science 2011, 334, 1081–1086. [Google Scholar] [CrossRef] [Green Version]
- Malhotra, J.D.; Kaufman, R.J. The endoplasmic reticulum and the unfolded protein response. Semin. Cell Dev. Biol. 2007, 18, 716–731. [Google Scholar]
- Pickart, C.M. Mechanisms Underlying Ubiquitination. Annu. Rev. Biochem. 2001, 70, 503–533. [Google Scholar] [CrossRef] [PubMed]
- Ciechanover, A.; Kwon, Y.T. Degradation of misfolded proteins in neurodegenerative diseases: Therapeutic targets and strategies. Exp. Mol. Med. 2015, 47, e147. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bertolotti, A.; Zhang, Y.; Hendershot, L.M.; Harding, H.P.; Ron, D. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat. Cell Biol. 2000, 2, 326–332. [Google Scholar] [CrossRef]
- Shore, G.C.; Papa, F.R.; Oakes, S. Signaling cell death from the endoplasmic reticulum stress response. Curr. Opin. Cell Biol. 2011, 23, 143–149. [Google Scholar] [CrossRef] [Green Version]
- Bhattarai, K.R.; Alam Riaz, T.; Kim, H.-R.; Chae, H.-J. The aftermath of the interplay between the endoplasmic reticulum stress response and redox signaling. Exp. Mol. Med. 2021, 53, 151–167. [Google Scholar] [CrossRef] [PubMed]
- Höhn, A.; Tramutola, A.; Cascella, R. Proteostasis Failure in Neurodegenerative Diseases: Focus on Oxidative Stress. Oxid. Med. Cell. Longev. 2020, 2020, 5497046. [Google Scholar] [CrossRef] [Green Version]
- Lindholm, D.; Wootz, H.; Korhonen, L. ER stress and neurodegenerative diseases. Cell Death Differ. 2006, 13, 385–392. [Google Scholar] [CrossRef]
- Borges, C.R.; Lake, D.F. Oxidative Protein Folding: Nature’s Knotty Challenge. Antioxid. Redox Signal. 2014, 21, 392–395. [Google Scholar] [CrossRef]
- Darby, N.J.; Creighton, T.E. Functional properties of the individual thioredoxin-like domains of protein disulfide isomerase. Biochemistry 1995, 34, 11725–11735. [Google Scholar] [CrossRef]
- Hwang, C.; Sinskey, A.J.; Lodish, H.F. Oxidized redox state of glutathione in the endoplasmic reticulum. Science 1992, 257, 1496–1502. [Google Scholar] [CrossRef] [PubMed]
- Bhandary, B.; Marahatta, A.; Kim, H.-R.; Chae, H.-J. An Involvement of Oxidative Stress in Endoplasmic Reticulum Stress and Its Associated Diseases. Int. J. Mol. Sci. 2012, 14, 434–456. [Google Scholar] [CrossRef] [PubMed]
- Nijholt, D.A.; van Haastert, E.S.; Rozemuller, A.J.; Scheper, W.; Hoozemans, J.J. The unfolded protein response is associated with early tau pathology in the hippocampus of tauopathies. J. Pathol. 2011, 226, 693–702. [Google Scholar] [CrossRef] [PubMed]
- Hoozemans, J.; van Haastert, E.; Eikelenboom, P.; de Vos, R.; Rozemuller, J.; Scheper, W. Activation of the unfolded protein response in Parkinson’s disease. Biochem. Biophys. Res. Commun. 2007, 354, 707–711. [Google Scholar] [CrossRef]
- Hetz, C.; Saxena, S. ER stress and the unfolded protein response in neurodegeneration. Nat. Rev. Neurol. 2017, 13, 477–491. [Google Scholar] [CrossRef]
- Torres, L.L.; Quaglio, N.B.; de Souza, G.T.; Garcia, R.T.; Dati, L.M.M.; Moreira, W.L.; Loureiro, A.P.D.M.; de Souza-Talarico, J.N.; Smid, J.; Porto, C.S.; et al. Peripheral Oxidative Stress Biomarkers in Mild Cognitive Impairment and Alzheimer’s Disease. J. Alzheimer’s Dis. 2011, 26, 59–68. [Google Scholar] [CrossRef]
- Markesbery, W.; Lovell, M. Four-Hydroxynonenal, a Product of Lipid Peroxidation, is Increased in the Brain in Alzheimer’s Disease. Neurobiol. Aging 1998, 19, 33–36. [Google Scholar] [CrossRef]
- Praticò, D.; Uryu, K.; Leight, S.; Trojanoswki, J.Q.; Lee, V.M.-Y. Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis. J. Neurosci. 2001, 21, 4183–4187. [Google Scholar] [CrossRef] [Green Version]
- Gwon, A.-R.; Park, J.-S.; Arumugam, T.V.; Kwon, Y.-K.; Chan, S.L.; Kim, S.-H.; Baik, S.-H.; Yang, S.; Yun, Y.-K.; Choi, Y.; et al. Oxidative lipid modification of nicastrin enhances amyloidogenic γ-secretase activity in Alzheimer’s disease. Aging Cell 2012, 11, 559–568. [Google Scholar] [CrossRef] [Green Version]
- Huang, X.; Atwood, C.S.; Hartshorn, M.A.; Multhaup, G.; Goldstein, L.E.; Scarpa, R.C.; Cuajungco, M.P.; Gray, D.N.; Lim, J.; Moir, R.D.; et al. The Aβ Peptide of Alzheimer’s Disease Directly Produces Hydrogen Peroxide through Metal Ion Reduction. Biochemistry 1999, 38, 7609–7616. [Google Scholar] [CrossRef]
- Liu, Y.; Nguyen, M.; Robert, A.; Meunier, B. Metal Ions in Alzheimer’s Disease: A Key Role or Not? Accounts Chem. Res. 2019, 52, 2026–2035. [Google Scholar] [CrossRef]
- Nieoullon, A.; Canolle, B.; Masmejean, F.; Guillet, B.; Pisano, P.; Lortet, S. The neuronal excitatory amino acid transporter EAAC1/EAAT3: Does it represent a major actor at the brain excitatory synapse? J. Neurochem. 2006, 98, 1007–1018. [Google Scholar] [CrossRef] [PubMed]
- Hodgson, N.; Trivedi, M.; Muratore, C.; Li, S.; Deth, R. Soluble Oligomers of Amyloid-β Cause Changes in Redox State, DNA Methylation, and Gene Transcription by Inhibiting EAAT3 Mediated Cysteine Uptake. J. Alzheimer’s Dis. 2013, 36, 197–209. [Google Scholar] [CrossRef] [PubMed]
- Ishikado, A.; Morino, K.; Nishio, Y.; Nakagawa, F.; Mukose, A.; Sono, Y.; Yoshioka, N.; Kondo, K.; Sekine, O.; Yoshizaki, T.; et al. 4-Hydroxy Hexenal Derived from Docosahexaenoic Acid Protects Endothelial Cells via Nrf2 Activation. PLoS ONE 2013, 8, e69415. [Google Scholar] [CrossRef] [PubMed]
- Casañas-Sánchez, V.; Pérez, J.A.; Fabelo, N.; Herrera-Herrera, A.V.; Fernández, C.; Marín, R.; González-Montelongo, M.C.; Díaz, M. Addition of docosahexaenoic acid, but not arachidonic acid, activates glutathione and thioredoxin antioxidant systems in murine hippocampal HT22 cells: Potential implications in neuroprotection. J. Neurochem. 2014, 131, 470–483. [Google Scholar] [CrossRef] [PubMed]
- Chew, H.; Solomon, V.A.; Fonteh, A.N. Involvement of Lipids in Alzheimer’s Disease Pathology and Potential Therapies. Front. Physiol. 2020, 11, 598. [Google Scholar] [CrossRef] [PubMed]
- Huang, T.L. Omega-3 Fatty Acids, Cognitive Decline, and Alzheimer’s Disease: A Critical Review and Evaluation of the Literature. J. Alzheimer’s Dis. 2010, 21, 673–690. [Google Scholar] [CrossRef]
- Díaz, M.; Mesa-Herrera, F.; Marín, R. DHA and Its Elaborated Modulation of Antioxidant Defenses of the Brain: Implications in Aging and AD Neurodegeneration. Antioxidants 2021, 10, 907. [Google Scholar] [CrossRef]
- Scheper, W.; Hoozemans, J.J.M.; Hoogenraad, C.C.; Rozemuller, A.J.M.; Eikelenboom, P.; Baas, F. Rab6 is increased in Alzheimer’s disease brain and correlates with endoplasmic reticulum stress. Neuropathol. Appl. Neurobiol. 2007, 33, 523–532. [Google Scholar] [CrossRef]
- Stutzbach, L.D.; Xie, S.X.; Naj, A.C.; Albin, R.; Gilman, S.; Lee, V.M.Y.; Trojanowski, J.Q.; Devlin, B.; Schellenberg, G.D. PSP Genetics Study Group The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer’s disease. Acta Neuropathol. Commun. 2013, 1, 31. [Google Scholar] [CrossRef] [Green Version]
- Cheng, H.; Wang, L.; Wang, C.-C. Domain a’ of protein disulfide isomerase plays key role in inhibiting α-synuclein fibril formation. Cell Stress Chaperones 2009, 15, 415–421. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ranjan, P.; Kumar, A. The Involvement of His50 during Protein Disulfide Isomerase Binding Is Essential for Inhibiting α-Syn Fibril Formation. Biochemistry 2016, 55, 2677–2680. [Google Scholar] [CrossRef]
- Serrano, A.; Qiao, X.; Matos, J.O.; Farley, L.; Cilenti, L.; Chen, B.; Tatulian, S.A.; Teter, K. Reversal of Alpha-Synuclein Fibrillization by Protein Disulfide Isomerase. Front. Cell Dev. Biol. 2020, 8, 726. [Google Scholar] [CrossRef] [PubMed]
- Conway, M.E.; Harris, M. Snitrosylation of the thioredoxin-like domains of protein disulfide isomerase and its role in neurodegenerative conditions. Front. Chem. 2015, 3, 27. [Google Scholar] [CrossRef] [Green Version]
- Kabiraj, P.; Marin, J.E.; Varela-Ramirez, A.; Zubia, E.; Narayan, M. Ellagic Acid Mitigates SNO-PDI Induced Aggregation of Parkinsonian Biomarkers. ACS Chem. Neurosci. 2014, 5, 1209–1220. [Google Scholar] [CrossRef] [PubMed]
- Wu, X.-F.; Wang, A.-F.; Chen, L.; Huang, E.-P.; Xie, W.-B.; Liu, C.; Huang, W.-Y.; Chen, C.-X.; Qiu, P.-M.; Wang, H.-J. S-nitrosylating protein disulphide isomerase mediates α-synuclein aggregation caused by methamphetamine exposure in PC12 cells. Toxicol. Lett. 2014, 230, 19–27. [Google Scholar] [CrossRef] [PubMed]
- Araki, K.; Iemura, S.-I.; Kamiya, Y.; Ron, D.; Kato, K.; Natsume, T.; Nagata, K. Ero1-α and PDIs constitute a hierarchical electron transfer network of endoplasmic reticulum oxidoreductases. J. Cell Biol. 2013, 202, 861–874. [Google Scholar] [CrossRef]
- Lang, C.; Campbell, K.R.; Ryan, B.J.; Carling, P.; Attar, M.; Vowles, J.; Perestenko, O.V.; Bowden, R.; Baig, F.; Kasten, M.; et al. Single-Cell Sequencing of iPSC-Dopamine Neurons Reconstructs Disease Progression and Identifies HDAC4 as a Regulator of Parkinson Cell Phenotypes. Cell Stem Cell 2019, 24, 93–106.e6. [Google Scholar] [CrossRef] [Green Version]
- Deas, E.; Cremades, N.; Angelova, P.R.; Ludtmann, M.; Yao, Z.; Chen, S.W.; Horrocks, M.H.; Banushi, B.; Little, D.; Devine, M.; et al. Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson’s Disease. Antioxid. Redox Signal. 2016, 24, 376–391. [Google Scholar] [CrossRef] [Green Version]
- Uversky, V.N.; Li, J.; Fink, A.L. Metal-triggered Structural Transformations, Aggregation, and Fibrillation of Human α-Synuclein: A Possible Molecular Link between Parkinson′ s Disease and Heavy Metal Exposure. J. Biol. Chem. 2001, 276, 44284–44296. [Google Scholar] [CrossRef] [Green Version]
- Helferich, A.M.; Ruf, W.P.; Grozdanov, V.; Freischmidt, A.; Feiler, M.S.; Zondler, L.; Ludolph, A.C.; McLean, P.J.; Weishaupt, J.H.; Danzer, K.M. α-synuclein interacts with SOD1 and promotes its oligomerization. Mol. Neurodegener. 2015, 10, 66. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jaronen, M.; Goldsteins, G.; Koistinaho, J. ER stress and unfolded protein response in amyotrophic lateral sclerosis—A controversial role of protein disulphide isomerase. Front. Cell. Neurosci. 2014, 8, 402. [Google Scholar] [CrossRef] [Green Version]
- Honjo, Y.; Ito, H.; Horibe, T.; Takahashi, R.; Kawakami, K. Protein Disulfide Isomerase Immunopositive Glial Cytoplasmic Inclusions in Patients with Multiple System Atrophy. Int. J. Neurosci. 2011, 121, 543–550. [Google Scholar] [CrossRef]
- Montibeller, L.; de Belleroche, J. Amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease (AD) are characterised by differential activation of ER stress pathways: Focus on UPR target genes. Cell Stress Chaperones 2018, 23, 897–912. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bella, E.D.; Tramacere, I.; Antonini, G.; Borghero, G.; Capasso, M.; Caponnetto, C.; Chiò, A.; Corbo, M.; Eleopra, R.; Filosto, M.; et al. Protein misfolding, amyotrophic lateral sclerosis and guanabenz: Protocol for a phase II RCT with futility design (ProMISe trial). BMJ Open 2017, 7, e015434. [Google Scholar] [CrossRef] [PubMed]
- Bella, E.D.; Bersano, E.; Antonini, G.; Borghero, G.; Capasso, M.; Caponnetto, C.; Chiò, A.; Corbo, M.; Filosto, M.; Giannini, F.; et al. The unfolded protein response in amyotrophic later sclerosis: Results of a phase 2 trial. Brain 2021, 144, 2635–2647. [Google Scholar] [CrossRef] [PubMed]
- Paul, B.D.; Sbodio, J.I.; Xu, R.; Vandiver, M.S.; Cha, J.Y.; Snowman, A.M.; Snyder, S.H. Cystathionine γ-lyase deficiency mediates neurodegeneration in Huntington’s disease. Nature 2014, 509, 96–100. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pinho, B.; Duarte, A.I.; Canas, P.; Moreira, P.; Murphy, M.P.; Oliveira, J.M. The interplay between redox signalling and proteostasis in neurodegeneration: In vivo effects of a mitochondria-targeted antioxidant in Huntington’s disease mice. Free Radic. Biol. Med. 2019, 146, 372–382. [Google Scholar] [CrossRef]
- Gaschler, M.M.; Stockwell, B.R. Lipid peroxidation in cell death. Biochem. Biophys. Res. Commun. 2017, 482, 419–425. [Google Scholar] [CrossRef]
- Magtanong, L.; Ko, P.-J.; To, M.; Cao, J.Y.; Forcina, G.C.; Tarangelo, A.; Ward, C.C.; Cho, K.; Patti, G.J.; Nomura, D.K.; et al. Exogenous Monounsaturated Fatty Acids Promote a Ferroptosis-Resistant Cell State. Cell Chem. Biol. 2019, 26, 420–432.e9. [Google Scholar] [CrossRef]
- Yu, H.; Guo, P.; Xie, X.; Wang, Y.; Chen, G. Ferroptosis, a new form of cell death, and its relationships with tumourous diseases. J. Cell. Mol. Med. 2016, 21, 648–657. [Google Scholar] [CrossRef] [PubMed]
- Miller, J.; Le Prell, C.G.; Rybak, L.P. Introduction: Free Radicals in ENT Pathology. In Free Radicals in ENT Pathology; Springer: Berlin/Heidelberg, Germany, 2015; pp. 3–6. [Google Scholar] [CrossRef]
- Ayala, A.; Muñoz, M.F.; Argüelles, S. Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal. Oxid. Med. Cell. Longev. 2014, 2014, 360438. [Google Scholar] [CrossRef] [PubMed]
- Hanafy, K.A.; Gomes, J.A.; Selim, M. Rationale and Current Evidence for Testing Iron Chelators for Treating Stroke. Curr. Cardiol. Rep. 2019, 21, 20. [Google Scholar] [CrossRef] [PubMed]
- Barbusiński, K. Fenton reaction—Controversy concerning the chemistry. Ecol. Chem. Eng. S 2009, 16, 347–358. [Google Scholar]
- Keuters, M.H.; Keksa-Goldsteine, V.; Dhungana, H.; Huuskonen, M.T.; Pomeshchik, Y.; Savchenko, E.; Korhonen, P.K.; Singh, Y.; Wojciechowski, S.; Lehtonen, L.; et al. An arylthiazyne derivative is a potent inhibitor of lipid peroxidation and ferroptosis providing neuroprotection in vitro and in vivo. Sci. Rep. 2021, 11, 3518. [Google Scholar] [CrossRef]
- Zhao, Z. Iron and oxidizing species in oxidative stress and Alzheimer’s disease. Aging Med. 2019, 2, 82–87. [Google Scholar] [CrossRef]
- Ursini, F.; Maiorino, M. Lipid peroxidation and ferroptosis: The role of GSH and GPx4. Free Radic. Biol. Med. 2020, 152, 175–185. [Google Scholar] [CrossRef]
- Savaskan, N.E.; Borchert, A.; Bräuer, A.U.; Kuhn, H. Role for glutathione peroxidase-4 in brain development and neuronal apoptosis: Specific induction of enzyme expression in reactive astrocytes following brain injury. Free Radic. Biol. Med. 2007, 43, 191–201. [Google Scholar] [CrossRef]
- Casañas-Sánchez, V.; Pérez, J.A.; Fabelo, N.; Quinto-Alemany, D.; Díaz, M.L. Docosahexaenoic (DHA) modulates phospholipid-hydroperoxide glutathione peroxidase (Gpx4) gene expression to ensure self-protection from oxidative damage in hippocampal cells. Front. Physiol. 2015, 6. [Google Scholar] [CrossRef] [Green Version]
- Sun, Y.; Zheng, Y.; Wang, C.; Liu, Y. Glutathione depletion induces ferroptosis, autophagy, and premature cell senescence in retinal pigment epithelial cells. Cell Death Dis. 2018, 9, 753. [Google Scholar] [CrossRef] [Green Version]
- Chen, L.; Hambright, W.S.; Na, R.; Ran, Q. Ablation of the Ferroptosis Inhibitor Glutathione Peroxidase 4 in Neurons Results in Rapid Motor Neuron Degeneration and Paralysis. J. Biol. Chem. 2015, 290, 28097–28106. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Reichert, C.O.; De Freitas, F.A.; Sampaio-Silva, J.; Rokita-Rosa, L.; Barros, P.D.L.; Levy, D.; Bydlowski, S.P. Ferroptosis Mechanisms Involved in Neurodegenerative Diseases. Int. J. Mol. Sci. 2020, 21, 8765. [Google Scholar] [CrossRef] [PubMed]
- Sun, Y.; Chen, P.; Zhai, B.; Zhang, M.; Xiang, Y.; Fang, J.; Xu, S.; Gao, Y.; Chen, X.; Sui, X.; et al. The emerging role of ferroptosis in inflammation. Biomed. Pharmacother. 2020, 127, 110108. [Google Scholar] [CrossRef] [PubMed]
- Nnah, I.C.; Wessling-Resnick, M. Brain Iron Homeostasis: A Focus on Microglial Iron. Pharmaceuticals 2018, 11, 129. [Google Scholar] [CrossRef] [Green Version]
- Hambright, W.S.; Fonseca, R.S.; Chen, L.; Na, R.; Ran, Q. Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration. Redox Biol. 2017, 12, 8–17. [Google Scholar] [CrossRef]
- Kapralov, A.A.; Yang, Q.; Dar, H.H.; Tyurina, Y.Y.; Anthonymuthu, T.S.; Kim, R.; St Croix, C.M.; Mikulska-Ruminska, K.; Liu, B.; Shrivastava, I.H.; et al. Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death. Nat. Chem. Biol. 2020, 16, 278–290. [Google Scholar] [CrossRef]
- Yang, W.S.; SriRamaratnam, R.; Welsch, M.E.; Shimada, K.; Skouta, R.; Viswanathan, V.S.; Cheah, J.H.; Clemons, P.A.; Shamji, A.F.; Clish, C.B.; et al. Regulation of Ferroptotic Cancer Cell Death by GPX4. Cell 2014, 156, 317–331. [Google Scholar] [CrossRef] [Green Version]
- Xu, T.; Ding, W.; Ji, X.; Ao, X.; Liu, Y.; Yu, W.; Wang, J. Molecular mechanisms of ferroptosis and its role in cancer therapy. J. Cell. Mol. Med. 2019, 23, 4900–4912. [Google Scholar] [CrossRef] [Green Version]
- Tuo, Q.-Z.; Lei, P.; Jackman, K.A.; Li, X.-L.; Xiong, H.; Liuyang, Z.-Y.; Roisman, L.C.; Zhang, S.-T.; Ayton, S.; Wang, Q.; et al. Tau-mediated iron export prevents ferroptotic damage after ischemic stroke. Mol. Psychiatry 2017, 22, 1520–1530. [Google Scholar] [CrossRef]
- Magtanong, L.; Dixon, S.J. Ferroptosis and Brain Injury. Dev. Neurosci. 2019, 40, 382–395. [Google Scholar] [CrossRef]
- Conrad, M.; Lorenz, S.M.; Proneth, B. Targeting Ferroptosis: New Hope for As-Yet-Incurable Diseases. Trends Mol. Med. 2020, 27, 113–122. [Google Scholar] [CrossRef] [PubMed]
- Jakaria; Belaidi, A.A.; Bush, A.I.; Ayton, S. Ferroptosis as a mechanism of neurodegeneration in Alzheimer’s disease. J. Neurochem. 2021, 159, 804–825. [Google Scholar] [CrossRef]
- Goodman, L. Alzheimer’s Disease: A clinico-pathologic analysis of twenty-three cases with a theory on pathogenesis. J. Nerv. Ment. Dis. 1953, 118, 97–130. [Google Scholar] [CrossRef] [PubMed]
- Liu, B.; Moloney, A.; Meehan, S.; Morris, K.; Thomas, S.E.; Serpell, L.; Hider, R.; Marciniak, S.; Lomas, D.A.; Crowther, D.C. Iron Promotes the Toxicity of Amyloid β Peptide by Impeding Its Ordered Aggregation. J. Biol. Chem. 2011, 286, 4248–4256. [Google Scholar] [CrossRef] [Green Version]
- Tao, Y.; Wang, Y.; Rogers, J.T.; Wang, F. Perturbed Iron Distribution in Alzheimer’s Disease Serum, Cerebrospinal Fluid, and Selected Brain Regions: A Systematic Review and Meta-Analysis. J. Alzheimer’s Dis. 2014, 42, 679–690. [Google Scholar] [CrossRef] [PubMed]
- Ansari, M.A.; Scheff, S.W. Oxidative Stress in the Progression of Alzheimer Disease in the Frontal Cortex. J. Neuropathol. Exp. Neurol. 2010, 69, 155–167. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chiang, G.C.; Mao, X.; Kang, G.; Chang, E.; Pandya, S.; Vallabhajosula, S.; Isaacson, R.; Ravdin, L.D.; Shungu, D.C.; the Alzheimer’s Disease Neuroimaging Initiative. Relationships among Cortical Glutathione Levels, Brain Amyloidosis, and Memory in Healthy Older Adults Investigated In Vivo with1H-MRS and Pittsburgh Compound-B PET. Am. J. Neuroradiol. 2017, 38, 1130–1137. [Google Scholar] [CrossRef] [Green Version]
- Tsatsanis, A.; Wong, B.; Gunn, A.P.; Ayton, S.; Bush, A.I.; Devos, D.; Duce, J.A. Amyloidogenic processing of Alzheimer’s disease β-amyloid precursor protein induces cellular iron retention. Mol. Psychiatry 2020, 25, 1958–1966. [Google Scholar] [CrossRef]
- Rao, S.; Adlard, P.A. Untangling Tau and Iron: Exploring the Interaction Between Iron and Tau in Neurodegeneration. Front. Mol. Neurosci. 2018, 11, 276. [Google Scholar] [CrossRef]
- Kagerer, S.M.; Van Bergen, J.M.G.; Li, X.; Quevenco, F.C.; Gietl, A.F.; Studer, S.; Treyer, V.; Meyer, R.; Kaufmann, P.A.; Nitsch, R.M.; et al. APOE4 moderates effects of cortical iron on synchronized default mode network activity in cognitively healthy old-aged adults. Alzheimer’s Dement. Diagn. Assess. Dis. Monit. 2020, 12, e12002. [Google Scholar] [CrossRef]
- Mahoney-Sánchez, L.; Bouchaoui, H.; Ayton, S.; Devos, D.; Duce, J.A.; Devedjian, J.-C. Ferroptosis and its potential role in the physiopathology of Parkinson’s Disease. Prog. Neurobiol. 2020, 196, 101890. [Google Scholar] [CrossRef] [PubMed]
- Vallerga, C.L.; Zhang, F.; Fowdar, J.; McRae, A.F.; Qi, T.; Nabais, M.; Zhang, Q.; Kassam, I.; Henders, A.K.; Wallace, L.; et al. Analysis of DNA methylation associates the cystine–glutamate antiporter SLC7A11 with risk of Parkinson’s disease. Nat. Commun. 2020, 11, 1238. [Google Scholar] [CrossRef] [Green Version]
- Di Domenico, F.; Tramutola, A.; Butterfield, D.A. Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders. Free Radic. Biol. Med. 2017, 111, 253–261. [Google Scholar] [CrossRef] [PubMed]
- Hopes, L.; Grolez, G.; Moreau, C.; Lopes, R.; Ryckewaert, G.; Carrière, N.; Auger, F.; Laloux, C.; Petrault, M.; Devedjian, J.-C.; et al. Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson’s Disease Stages? PLoS ONE 2016, 11, e0147947. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bellinger, F.P.; Bellinger, M.T.; Seale, L.A.; Takemoto, A.S.; Raman, A.V.; Miki, T.; Manning-Boğ, A.B.; Berry, M.J.; White, L.R.; Ross, G.W. Glutathione Peroxidase 4 is associated with Neuromelanin in Substantia Nigra and Dystrophic Axons in Putamen of Parkinson’s brain. Mol. Neurodegener. 2011, 6, 8–10. [Google Scholar] [CrossRef] [Green Version]
- Cao, J.; Chen, X.; Jiang, L.; Lu, B.; Yuan, M.; Zhu, D.; Zhu, H.; He, Q.; Yang, B.; Ying, M. DJ-1 suppresses ferroptosis through preserving the activity of S-adenosyl homocysteine hydrolase. Nat. Commun. 2020, 11, 1251. [Google Scholar] [CrossRef] [Green Version]
- Devos, D.; Moreau, C.; Devedjian, J.C.; Kluza, J.; Petrault, M.; Laloux, C.; Jonneaux, A.; Ryckewaert, G.; Garcon, G.; Rouaix, N.; et al. Targeting Chelatable Iron as a Therapeutic Modality in Parkinson’s Disease. Antioxid. Redox Signal. 2014, 21, 195–210. [Google Scholar] [CrossRef] [Green Version]
- Perluigi, M.; Poon, H.F.; Hensley, K.; Pierce, W.M.; Klein, J.B.; Calabrese, V.; De Marco, C.; Butterfield, D.A. Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice-A model of familial amyotrophic lateral sclerosis. Free Radic. Biol. Med. 2005, 38, 960–968. [Google Scholar] [CrossRef]
- Valentine, J.S. Do oxidatively modified proteins cause ALS? Free Radic. Biol. Med. 2002, 33, 1314–1320. [Google Scholar] [CrossRef]
- Chen, L.; Na, R.; McLane, K.D.; Thompson, C.S.; Gao, J.; Wang, X.; Ran, Q. Overexpression of ferroptosis defense enzyme Gpx4 retards motor neuron disease of SOD1G93A mice. Sci. Rep. 2021, 11, 12890. [Google Scholar] [CrossRef]
- Southon, A.; Szostak, K.; Acevedo, K.M.; Dent, K.A.; Volitakis, I.; Belaidi, A.A.; Barnham, K.J.; Crouch, P.; Ayton, S.; Donnelly, P.S.; et al. Cu II (atsm) inhibits ferroptosis: Implications for treatment of neurodegenerative disease. J. Cereb. Blood Flow Metab. 2019, 177, 656–667. [Google Scholar] [CrossRef] [PubMed]
- Mi, Y.; Gao, X.; Xu, H.; Cui, Y.; Zhang, Y. The Emerging Roles of Ferroptosis in Huntington’s Disease. NeuroMolecular Med. 2019, 21, 110–119. [Google Scholar] [CrossRef] [PubMed]
- Rosas, H.D.; Chen, Y.I.; Doros, G.; Salat, D.H.; Chen, N.-K.; Kwong, K.K.; Bush, A.; Fox, J.; Hersch, S.M. Alterations in Brain Transition Metals in Huntington Disease. Arch. Neurol. 2012, 69, 887–893. [Google Scholar] [CrossRef] [PubMed]
- Lee, J.; Kosaras, B.; Del Signore, S.J.; Cormier, K.; McKee, A.; Ratan, R.R.; Kowall, N.W.; Ryu, H. Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington’s disease mice. Acta Neuropathol. 2010, 121, 487–498. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Choo, Y.S.; Johnson, G.V.W.; MacDonald, M.; Detloff, P.J.; Lesort, M. Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Hum. Mol. Genet. 2004, 13, 1407–1420. [Google Scholar] [CrossRef]
- Guo, X.; Disatnik, M.-H.; Monbureau, M.; Shamloo, M.; Mochly-Rosen, D.; Qi, X. Inhibition of mitochondrial fragmentation diminishes Huntington’s disease–associated neurodegeneration. J. Clin. Investig. 2013, 123, 5371–5388. [Google Scholar] [CrossRef]
- Yano, H.; Baranov, S.V.; Baranova, O.V.; Kim, J.; Pan, Y.; Yablonska, S.; Carlisle, D.L.; Ferrante, R.J.; Kim, A.H.; Friedlander, R. Inhibition of mitochondrial protein import by mutant huntingtin. Nat. Neurosci. 2014, 17, 822–831. [Google Scholar] [CrossRef]
- Muller, M.; Leavitt, B.R. Iron dysregulation in Huntington’s disease. J. Neurochem. 2014, 130, 328–350. [Google Scholar] [CrossRef] [Green Version]
- Homma, T.; Kobayashi, S.; Sato, H.; Fujii, J. Edaravone, a free radical scavenger, protects against ferroptotic cell death in vitro. Exp. Cell Res. 2019, 384, 111592. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Goldsteins, G.; Hakosalo, V.; Jaronen, M.; Keuters, M.H.; Lehtonen, Š.; Koistinaho, J. CNS Redox Homeostasis and Dysfunction in Neurodegenerative Diseases. Antioxidants 2022, 11, 405. https://doi.org/10.3390/antiox11020405
Goldsteins G, Hakosalo V, Jaronen M, Keuters MH, Lehtonen Š, Koistinaho J. CNS Redox Homeostasis and Dysfunction in Neurodegenerative Diseases. Antioxidants. 2022; 11(2):405. https://doi.org/10.3390/antiox11020405
Chicago/Turabian StyleGoldsteins, Gundars, Vili Hakosalo, Merja Jaronen, Meike Hedwig Keuters, Šárka Lehtonen, and Jari Koistinaho. 2022. "CNS Redox Homeostasis and Dysfunction in Neurodegenerative Diseases" Antioxidants 11, no. 2: 405. https://doi.org/10.3390/antiox11020405
APA StyleGoldsteins, G., Hakosalo, V., Jaronen, M., Keuters, M. H., Lehtonen, Š., & Koistinaho, J. (2022). CNS Redox Homeostasis and Dysfunction in Neurodegenerative Diseases. Antioxidants, 11(2), 405. https://doi.org/10.3390/antiox11020405